PharmAbcine Inc. announced a private placement of 10,672,359 common shares at an issue price of KRW 2,811 for the gross proceeds of KRW 30,000,001,149 on June 16, 2023. The transaction will include participation from new investor PharmAbcine Diamond Club Mutual Growth Equity Fund. The transaction has been approved by the board of directors of the company.

The transaction is expected to close on July 26, 2023.